GeoVax Labs, Inc. Share Price
NASDAQ: GOVX | Micro CapGeoVax Labs, Inc. Stock Performance
GeoVax Labs, Inc. Share Price Today
As of 30 October 2026, GeoVax Labs, Inc.'s share price is $0.19. The stock opened at $0.19, compared to its previous close of $0.20. During today's trading session, GeoVax Labs, Inc.'s share price traded between $0.19 and $0.19, with an average price of $0.19. Over the past 52 weeks, the stock has recorded a high of $4.36 and a low of $0.12. In terms of performance, GeoVax Labs, Inc.'s share price has declined by 80.89% over the last six months and is down 66.08% on a year-on-year basis.
GeoVax Labs, Inc. Share Price Chart
GeoVax Labs, Inc. Quarterly Profit & Loss
All figures in USD
GeoVax Labs, Inc. Annual Profit & Loss
All figures in USD
About GeoVax Labs, Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.
GeoVax Labs, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $0.33 | $0.19 | -45.80% |
Sep 2026 | $0.60 | $0.34 | -53.50% |
Aug 2026 | $0.73 | $0.74 | +4.07% |
Jul 2026 | $1.27 | $0.71 | -42.96% |
Jun 2026 | $2.27 | $1.25 | -40.76% |
May 2026 | $1.14 | $2.11 | +114.65% |
Apr 2026 | $1.39 | $0.98 | -26.09% |
Mar 2026 | $1.60 | $1.33 | -17.90% |
Feb 2026 | $2.74 | $1.62 | -42.04% |
Jan 2026 | $0.18 | $2.79 | +1,497.14% |
Dec 2025 | $0.41 | $0.17 | -57.42% |
Nov 2025 | $0.56 | $0.41 | -25.81% |